1. Yamada, G.; Takatani, M.; Kishi, F.; Takahashi, M.; Doi,

T.; Tsuji, T.; Shin, S.; Tanno, M.; Urdea, M.S.; Kolberg, 14. J.A. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 1995, 22, 1351-1354.

2. Zeuzem, S.; Lee, J.H.; Franke, A.; Ruster, B.; Prummer,

O.; Herrmann, G.; Roth, W.K. Quantification of the initial 15. decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology 1998, 27, 1149-1156.

3. Klapper, P.E.; Jungkind, D.L.; Fenner, T.; Antinozzi, R.; Schirm, J.; Blanckmeister, C. Multicenter international work flow study of an automated polymerase chain 16. reaction instrument. Clin. Chem. 1998, 44, 1737-1739.

4. Dailey, P.J.; Hyden, D. Viral Load Assays: Methodologies, Variables and Interpretation. In The AIDS Knowledge

Basic, 3rd Ed.; Cohen, P.T., Sande, M.A., Volberding, 17. P.A., Eds.; Lippincott-Rawen: Philadelphia, 1999; 119130. Chapter 13.

5. Nolte, F.S.; Thurmond, C.; Fried, M.W. Preclinical evaluation of AMPLICOR hepatitis C virus test for 18. detection of hepatitis C virus RNA. J. Clin. Microbiol.

1995, 33, 1775-1778.

6. Sung, L.C.; Antony, A.; Lee, N.; Leibow, J.; Yang, J.Q.; Soviero, S.; Gutekunst, K.; Rosenstraus, M. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus 19. RNA: Calibration to international units, enhanced genotype reactivity, and performance characteristics. J. Clin. Microbiol. 2000, 38 (11), 4171-4179.

Mellor, J.; Hawkins, A.; Simmonds, P. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J. Clin. Microbiol. 1999, 37, 2525-2532.

Jungkind, D.; Direnzo, S.; Beavis, G.; Silverman, N.S. Evaluation of automated COBAS AMPLICOR PCR system for detection of several infectious agents and its impact on laboratory management. J. Clin. Microbiol. 1996, 34 (11), 2778-2783.

Kessler, H.H.; Dragon, E.A.; Pierer, K.; Santner, B.I.; Liao, Y.; Stuenzner, D.; Stelzl, E.; Marth, E. Performance of the automated COBAS AMPLICOR system for the detection of hepatitis C virus RNA. Clin. Diagn. Virol. 1997, 7 (3), 139-145.

Tong, M.J.; Hwang, S.J.; Lefkowitz, M.; Lee, S.D.; Co, R.L.; Conrad, A.; Schmid, P.; Lo, K.J. Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin. J. Gastroenterol. Hepatol. 1994, 9, 587-591. Reichard, O.; Norkrans, G.; Fryden, A.; Braconier, J.H.; Sonnerborg, A.; Weiland, O. Comparison of 3 quantitative HCV RNA assays—Accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C. Scand. J. Infect. Dis. 1998, 30, 441-446.

Damen, M.; Sillekens, P.; Cuypers, H.T.; Frantzen, I.; Melsert, R. Characterization of the quantitative HCV NASBA assay. J. Virol. Methods 1999, 82 (1), 45-54. Morris, T.; Robertson, B.; Gallagher, M. Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system. J. Clin. Microbiol. 1996, 34 (12), 2933-2936. Takeuchi, T.; Katsume, A.; Tanaka, T.; Abe, A.; Inoue, K.; Tsukiyama-Kohara, K.; Kawaguchi, R.; Tanaka, S.; Kohara, M. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 1999, 116 (3), 636-642.

Detmer, J.; Lagier, R.; Flynn, J.; Zayati, C.; Kolberg, J.; Collins, M.; Urdea, M.; Sanchez-Pescador, R. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J. Clin. Microbiol. 1996, 34 (4), 901-907. Aoyagi, K.; Ohue, C.; Iida, K.; Kimura, T.; Tanaka, E.; Kiyosawa, K.; Yagi, S. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J. Clin. Microbiol. 1999, 37 (6), 1802-1808. Pawlotsky, J.M.; Bouvier-Alias, M.; Hezode, C.; Darthuy, F.; Remire, J.; Dhumeaux, D. Standardization of hepatitis C virus RNA quantification. Hepatology 2000, 32 (3), 654-659.

Konnick, E.Q.; Erali, M.; Ashwood, E.R.; Hillyard, D.R. Performance characteristics of the COBAS Amplicor hepatitis C virus (HCV) monitor, version 2.0, international unit assay and the National Genetics Institute HCV Superquant assay. J. Clin. Microbiol. 2002, 40 (3), 768773.

Beld, M.; Sentjens, R.; Rebers, S.; Weegink, C.; Weel, J.; Sol, C.; Boom, R. Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: Conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, version 2.0, assay. J. Clin. Microbiol. 2002, 40, 788-793.

20. Zanetti, A.R.; Romano, L.; Brunetto, M.; Colombo, M.; Bellati, G.; Tackney, C. Total HCV core antigen assay: A new marker of hepatitis C viremia for monitoring the progress of therapy. J. Med. Virol. 2003, 70 (1), 27 - 30.

21. Stelzl, E.; Kormann-Klement, A.; Haas, J.; Daghofer, E.; Santner, B.I.; Marth, E.; Kessler, H.H. Evaluation of an automated sample preparation protocol for quantitative detection of hepatitis C virus RNA. J. Clin. Microbiol. 2002, 40 (4), 1447-1450.

22. EASL Consensus Panel 1999. EASL International Consensus Conference on Hepatitis C, Paris, February 26-28, 1999. J. Hepatol. 1999, 30, 956-961.

23. NIH Consensus Development Conference Statement: Management of Hepatitis C: (June 10-12) 2002, Final

Statement; Revisions made September 12, 2GG2. consensus.

24. Saldanha, J.; Lelie, N.; Heath, A. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA WHO Collaborative Study Group. Vox Sang. 1999, 76 (3), 149158.

25. Shiffman, M.L.; Ferreira-Gonzalez, A.; Reddy, K.R.; Sterling, R.K.; Luketic, V.A.; Stravitz, R.T.; Sanyal, A.J.; Garrett, C.T.; De Medina, M.; Schiff, E.R. Comparison of three commercially available assays for HCV RNA using the international unit standard: Implications for management of patients with chronic hepatitis C virus infection in clinical practice. Am. J. Gastroenterol. 2003, 98 (5), 1159-1166.

26. Quality Control for Molecular Diagnostics (QCMD).

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook

Post a comment